← Back to Search

Emotional Resilience Training for PTSD

N/A
Recruiting
Led By R. Nicholas Carleton, PhD
Research Sponsored by University of Regina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time 2 (post-training; week 26), time 3 (1-year follow-up), time 4 (2-year follow-up), time 5 (3-year follow-up), time 6 (4-year follow-up), time 7 (5-year follow-up)
Awards & highlights

Study Summary

This trial is investigating whether a new training program for the Royal Canadian Mounted Police (RCMP) can help reduce posttraumatic stress injuries (PTSI).

Who is the study for?
This trial is specifically for cadets beginning the RCMP Cadet Training Program. It aims to study mental health risk and resilience factors related to traumatic stress. Only these cadets can participate, excluding anyone else not starting this program.Check my eligibility
What is being tested?
The trial tests Emotional Resilience Skills Training (ERST) against Active Monitoring in new RCMP cadets. They'll be assessed before and after training, then annually for five years, plus with monthly and daily surveys to measure mental health outcomes.See study design
What are the potential side effects?
Since the interventions involve skills training and monitoring rather than medical treatments, traditional side effects are not expected; however, participants may experience emotional discomfort or stress during the process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time 2 (post-training; week 26), time 3 (1-year follow-up), time 4 (2-year follow-up), time 5 (3-year follow-up), time 6 (4-year follow-up), time 7 (5-year follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and time 2 (post-training; week 26), time 3 (1-year follow-up), time 4 (2-year follow-up), time 5 (3-year follow-up), time 6 (4-year follow-up), time 7 (5-year follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Generalized Anxiety Disorder Symptoms from Time 1 (pre-training; week 1) to Time 2 (post-training; week 26)
Unipolar Depression
Panic Disorder
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Augmented Training Condition (ATC)Experimental Treatment1 Intervention
The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UP) is an evidence-based cognitive-behavioral intervention designed to cultivate constructive approach-oriented emotional engagement. The 13-week Emotional Resilience Training (ERST) is an adaptation of the UP designed for use as a proactive training course. The ERST frames emotional experiences as natural responses to threat, rather than pathological occurrences to avoid; as such, the ERST is well-suited for mitigating health challenges and the skills may also help PSP to support persons in distress, including other PSP and the community members they all serve. The ERST training materials include an instructor guide, didactic PowerPoints, and a trainee workbook. The ERST was designed for seamless integration with the Cadet Training Program, effective June 2022, which is what creates the augmented training arm (i.e., the ATC).
Group II: Standard Training Condition (STC)Active Control1 Intervention
The STC has received the "standard" RCMP Depot Division ("Depot") Cadet Training Program as has been provided to cadets prior to June 2022. The STC and the ATC will complete the same standardized self-report assessments, clinical interview assessments, and biometric assessments, and receive the same feedback and reporting based on those assessments.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Generalized Anxiety Disorder (GAD) include pharmacological and psychotherapeutic approaches. SSRIs and SNRIs increase serotonin and norepinephrine levels in the brain, helping to regulate mood and reduce anxiety. Buspirone acts as a partial agonist at serotonin receptors, alleviating anxiety symptoms. Cognitive Behavioral Therapy (CBT) involves cognitive restructuring and behavioral interventions to change negative thought patterns and behaviors. These treatments are crucial for GAD patients as they address the neurochemical and cognitive processes underlying anxiety, offering both immediate and sustained relief.
The Effect of Melatonin Upon Postacute Withdrawal Among Males in a Residential Treatment Program (M-PAWS): A Randomized, Double-blind, Placebo-controlled Trial.

Find a Location

Who is running the clinical trial?

University of ReginaLead Sponsor
49 Previous Clinical Trials
7,648 Total Patients Enrolled
2 Trials studying Generalized Anxiety Disorder
217 Patients Enrolled for Generalized Anxiety Disorder
Royal Canadian Mounted PoliceUNKNOWN
Government of CanadaOTHER_GOV
12 Previous Clinical Trials
1,407 Total Patients Enrolled

Media Library

Emotional Resilience Skills Training (ERST) Clinical Trial Eligibility Overview. Trial Name: NCT05527509 — N/A
Generalized Anxiety Disorder Research Study Groups: Augmented Training Condition (ATC), Standard Training Condition (STC)
Generalized Anxiety Disorder Clinical Trial 2023: Emotional Resilience Skills Training (ERST) Highlights & Side Effects. Trial Name: NCT05527509 — N/A
Emotional Resilience Skills Training (ERST) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05527509 — N/A
~72 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top